Aspire Biopharma Holdings, Inc. (ASBP) Earnings History

Quarterly EPS Results — source: SEC EDGAR
QuarterEPS EstimateEPS ActualSurpriseResult
Q22026 FY2026—$1.00—Miss
Q12026 FY2026—$-20.57—Miss

Back to ASBP overview · ASBP holders · ASBP KPIs

Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.